How much funding has XLOCK BIOSCIENCES, LLC raised?

XLOCK BIOSCIENCES, LLC has raised $360K in total funding, most recently a Venture Round.

Who are XLOCK BIOSCIENCES, LLC's investors?

XLOCK BIOSCIENCES, LLC's investors include National Institutes of Health.

When was XLOCK BIOSCIENCES, LLC founded?

XLOCK BIOSCIENCES, LLC was founded in 2020.

Where is XLOCK BIOSCIENCES, LLC headquartered?

XLOCK BIOSCIENCES, LLC is headquartered in MUSKEGO, Wisconsin, United States.

What industry is XLOCK BIOSCIENCES, LLC in?

XLOCK BIOSCIENCES, LLC operates in Biotech, Healthcare.

How many employees does XLOCK BIOSCIENCES, LLC have?

XLOCK BIOSCIENCES, LLC has 1-10 employees.

XLOCK BIOSCIENCES, LLC

Harnessing the potential of chemokine biology

MUSKEGO, United States · Founded 2020 · $360K raised

Biotech

Healthcare

Headquarters: MUSKEGO, Wisconsin
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: xlockbio.com
Total Funding: $360K
Last Round: $100K Venture RoundJan 2022
Rounds: 2

About

XLock Biosciences is a clinical-stage biotech company harnessing chemokine biology to develop next-generation precision therapeutics in immunology and oncology. Using deep expertise in protein engineering and immune system modulation, XLock's lead compound CCL20 Locked Dimer (CCL20LD) selectively targets disease-driving Th17-mediated pathways. The company has demonstrated preclinical efficacy in psoriasis, psoriatic arthritis, and chronic graft-versus-host disease.

Summary

XLOCK BIOSCIENCES, LLC is a Biotech company based in MUSKEGO, United States, founded in 2020. It has raised $360K in total across 2 rounds, most recently a $100K Venture Round round in Jan 2022. Investors include National Institutes of Health.

LinkedIn X (Twitter)